English 
Japanese 
Published on: December 18, 2025
PRISM BioLab and Talus Bioscience, Inc. are pleased to announce that we have entered into a joint research agreement to discover novel inhibitors targeting transcription factors and protein-protein interactions (PPIs).
For more details, please click here.